Voorbeelden van het gebruik van Plasma exchange in het Engels en hun vertalingen in het Nederlands
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
Plasmapheresis or plasma exchange.
In plasma exchange, the patient's blood is separated into blood cells and plasma. .
He didn't respond to the plasma exchange.
Subjects who undergo plasma exchange may receive additional doses of Soliris.
Eugene's infection isn't responding to the plasma exchange.
Neither dialysis nor plasma exchange results in removal of fingolimod from the body.
Within 60 minutes after each plasmapheresis or plasma exchange.
The impact of plasma exchange on the restitution of lymphocyte migration
half-life of eculizumab were also evaluated during plasma exchange interventions.
The effect of plasma exchange on natalizumab clearance and pharmacodynamics was evaluated in a study of 12 MS patients.
could not be treated with plasma exchange or infusion.
prompt treatment is required(considering plasma exchange) and immediate discontinuation of Extavia is recommended.
and plasmapheresis plasma exchange.
If TMA is diagnosed, prompt treatment is required(considering plasma exchange) and immediate discontinuation of Rebif is recommended.
Plasma exchange resulted in an approximately 50% decline in eculizumab concentrations following a 1 hour intervention
Estimates of the total natalizumab removal after 3 plasma exchanges(over a 5-8 day interval)
For adults and paediatric aHUS patients supplemental dosing of Soliris is required in the setting of concomitant PE/PI plasmapheresis or plasma exchange, or fresh frozen plasma infusion.
Intravenous polyclonal immunoglobulins and plasma exchanges should be envisaged in NEP-deficient mothers with increasing titres of anti-NEP IgG1.
platelet count after starting Soliris and did not require plasma exchange or infusion, or dialysis)
In this study too, plasma exchange was carried out to bring down the FH antibody levels along with the administration of rituximab for a period of four months to maintain low antibody levels.
Monitoring for development of IRIS, which has occurred within days to several weeks after plasma exchange in TYSABRI treated patients with PML, and appropriate treatment of
Interventional studies such as plasma exchange along with the administration of immunosuppressive agents have been conducted
manganese ions are released from the mangafodipir by exchange with plasma zinc(mainly) after intravenous administration.